DSM-Firmenich AG (DSFIY)

OTCMKTS · Delayed Price · Currency is USD
8.36
-0.10 (-1.18%)
Feb 11, 2026, 1:31 PM EST
Market Cap20.75B -23.4%
Revenue (ttm)15.28B +4.5%
Net Income843.22M
EPS3.19
Shares Outn/a
PE Ratio24.61
Forward PE19.27
Dividend0.22 (2.79%)
Ex-Dividend DateMay 12, 2025
Volume161
Average Volume611,553
Open8.25
Previous Close8.46
Day's Range8.24 - 8.43
52-Week Range7.62 - 11.57
Beta0.89
RSI56.34
Earnings DateFeb 12, 2026

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]

Sector Materials
Founded 1902
Employees 28,608
Stock Exchange OTCMKTS
Ticker Symbol DSFIY
Full Company Profile

Financial Performance

In 2024, DSM-Firmenich AG's revenue was 12.80 billion, an increase of 20.44% compared to the previous year's 10.63 billion. Earnings were 250.00 million, a decrease of -88.27%.

Financial numbers in EUR Financial Statements

News

DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript

DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript

2 days ago - Seeking Alpha

dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)

Press Release dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH) Kaiseraugst (Switzerland), Maastricht (Netherlands), February...

2 days ago - GlobeNewsWire

DSM-Firmenich to Sell Animal Nutrition Unit to CVC in $2.6 Billion Deal

The sale to CVC Capital Partners marks the final step in its plan to fully focus on human nutrition, health and beauty.

2 days ago - WSJ

DSM-Firmenich to sell animal health business to CVC Capital

Chemicals company DSM-Firmenich has agreed to sell its Animal Nutrition & Health business to CVC Capital for an enterprise value of around 2.2 billion euros ($2.6 billion), it said on Monday.

2 days ago - Reuters

dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

Press Release dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovat...

2 days ago - GlobeNewsWire

dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer

Press Release dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer Kaiseraugst (Switzerland), Maastricht (Netherlands), January 14, 2026 dsm-firmenich, the leading innovator i...

4 weeks ago - GlobeNewsWire

Goldman Sachs International Equity ESG Fund Q3 2025 Portfolio Review

Goldman Sachs International Equity ESG Fund initiated a position in ING Group (2.6%), a Dutch global financial institution. We initiated a position in Air Liquide (2.0%), which produces, markets, and ...

2 months ago - Seeking Alpha

DSM-Firmenich: High-Quality Value Play

DSM-Firmenich, formed by the merger of DSM and Firmenich, faces challenges post-merger, including the sale of the ANH division. The stock has experienced a significant price decline, presenting a pote...

2 months ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q3 2025 Sales Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q3 2025 Sales Call October 30, 2025 4:00 AM EDT Company Participants Dave Huizing - Senior Vice President of Investor Relations Dimitri de Vreeze - Chief Executive Officer...

3 months ago - Seeking Alpha

dsm-firmenich Q3 2025 trading update

Press Release Kaiseraugst (Switzerland), Maastricht (Netherlands), October 30, 2025 dsm-firmenich Q3 2025 trading update Management Report Q3 2025 highlights Solid growth and strong step up in Adjuste...

3 months ago - GlobeNewsWire

Artisan International Value Fund Q3 2025 Portfolio Update

Major joint customer announcements about new products and significant future orders combined with strong demand for basic memory semiconductors drove renewed interest in Samsung Electronics stock. ABB...

3 months ago - Seeking Alpha

DSM-Firmenich: A Widening Moat At A Discount

DSM-Firmenich leverages scale, proprietary R&D, and customer stickiness to enhance its position in specialty ingredients, flavors, and fragrances. DSM-Firmenich delivered 7% organic sales growth and a...

5 months ago - Seeking Alpha

dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company

Press Release dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company Kaiseraugst (Switzerland), Maastricht (Netherlands), September 1, 2025 dsm-firmenich is ...

5 months ago - GlobeNewsWire

DSM-Firmenich AG (DSFIY) Q2 2025 Earnings Call Transcript

DSM-Firmenich AG (OTCQX:DSFIY) Q2 2025 Earnings Conference Call July 31, 2025 3:00 AM ET Company Participants Dave Huizing - Senior Vice President of Investor Relations Dimitri de Vreeze - Chief Execu...

6 months ago - Seeking Alpha

dsm-firmenich reports H1 2025 results

Press Release Kaiseraugst (Switzerland), Maastricht (Netherlands), July 31, 2025 dsm-firmenich reports H1 2025 results Management Report H1 2025 highlights Good first half of the year, with good organ...

6 months ago - GlobeNewsWire

Dsm-firmenich's animal feed unit sale attracts three final bidders, Dutch paper reports

Dsm-firmenich's is close to selling its animal nutrition business, with final bids expected from private equity firms CVC , Apollo and Dutch rival Nutreco, Dutch newspaper Financieele Dagblad reported...

7 months ago - Reuters

dsm-firmenich announces redemption of €750 million hybrid bond

Press Release dsm-firmenich announces redemption of € 750 million hybrid bond Kaiseraugst (Switzerland), Maastricht (Netherlands), July 1, 2025 dsm-firmenich, innovators in nutrition, health, and beau...

8 months ago - GlobeNewsWire

dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

Press Release dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 27, 2025 dsm-firmenich, innovators ...

8 months ago - GlobeNewsWire

dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

Press Release dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 2, 2025 dsm-firmenich, innovato...

9 months ago - GlobeNewsWire

dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025

Press Release dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025 Kaiseraugst (Switzerland), Maastricht (Netherlands), May 6, 2025 dsm-firmenich, innovators in nutrition,...

10 months ago - GlobeNewsWire

DSM-Firmenich AG (KDSKF) Q1 2025 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q1 2025 Results Conference Call April 30, 2025 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference...

10 months ago - Seeking Alpha

Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

Press Release Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich Kaiseraugst (Switzerland), Maastricht (Netherlands), April 8, 2025 dsm-firmenich, innovators in nutrit...

11 months ago - GlobeNewsWire

dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

Press Release dsm-firmenich completes shareholding increase in Andre Pectin to 90.5% Kaiseraugst (Switzerland), Maastricht (Netherlands), April 3, 2025 dsm-firmenich, innovators in nutrition, health, ...

11 months ago - GlobeNewsWire

Human Milk Oligosaccharides (HMOs) Market Insights 2025, Analysis and Forecast to 2030 Featuring Key Companies - DSM-Firmenich, Kyowa Hakko, and Chr. Hansen

Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Human Milk Oligosaccharides (HMOs) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Produ...

11 months ago - GlobeNewsWire

dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day

Press Release dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day Kaiseraugst (Switzerland), Maastricht (Netherlands), March 25, 2025 ...

11 months ago - GlobeNewsWire